Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SARS-CoV-2-specific immune responses after COVID-19 vaccination in solid organ transplant recipients
TCTR20210523002Phase 4Completed
- Sponsor
- Faculty of Medicine Ramathibodi Hospital, Mahidol University
- Start
- Aug 2021
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial in coronavirus disease 2019 (COVID-19), sponsored by Faculty of Medicine Ramathibodi Hospital, Mahidol University. Primary endpoint: SARS-CoV-2-specific immune response. Started Aug 2021; status: completed.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20210523002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210523002.